During the past decade, Instituto de Moléstias Cardiovasculares de Tatuí conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Instituto de Moléstias Cardiovasculares de Tatuí" #1 sponsor was "EMS" with 2 trials, followed by "Bayer" with 1 trials sponsored, "Eli Lilly and Company" with 1 trials sponsored, "Eurofarma Laboratorios S.A." with 1 trials sponsored and "Kowa Research Institute, Inc." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Instituto de Moléstias Cardiovasculares de Tatuí" #1 collaborator was "Brigham and Women's Hospital" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Instituto de Moléstias Cardiovasculares de Tatuí" are "Asthma" (2 trials), "Heart Failure" (2 trials), "Arterial Hypertension" (1 trials), "Dyslipidemia" (1 trials) and "Heart Failure With Preserved Ejection Fraction" (1 trials). Many other conditions were trialed in "Instituto de Moléstias Cardiovasculares de Tatuí" in a lesser frequency.

Most popular intervention types in "Instituto de Moléstias Cardiovasculares de Tatuí" are "Drug" (6 trials) and "Other" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Budesonide / Formoterol 400/12" (1 trials), "Budesonide / Formoterol 400/12 Placebo" (1 trials), "Budesonide/formoterol 200/6" (1 trials) and "Budesonide/formoterol 200/6 placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Instituto de Moléstias Cardiovasculares de Tatuí" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Instituto de Moléstias Cardiovasculares de Tatuí". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Instituto de Moléstias Cardiovasculares de Tatuí, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Instituto de Moléstias Cardiovasculares de Tatuí, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".